A recent study published in The New England Journal of Medicine has found that elinzanetant, a therapy targeted at neurokinin ...

As recommendations suggest extending hormone-based breast cancer treatment to 10 years for some patients, a new study sheds light on whether patients are opting for it.

Current technologies, and those in the pipeline and beyond, could advance the management of diabetes comorbidities, George Grunberger, MD, FACP, FACE, said during a presentation at the Heart in ...

Hepatitis C virus (HCV) infection is highly associated with the development of metabolic dysfunction-associated steatotic ...

As recommendations suggest extending hormone-based breast cancer treatment to 10 years for some patients, a new study sheds ...

As recommendations suggest extending hormone-based breast cancer treatment to 10 years for some patients, a new study sheds ...

Canada: A new large-scale study from Canada has found that the use of statins —commonly prescribed cholesterol-lowering drugs ...

Researchers identified a biomarker that may predict the recurrence of a diabetic foot ulcer that had previously healed. In a ...

Niagen Bioscience, Inc. (NASDAQ: NAGE) (formerly ChromaDex Corp.), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, shares positive ...